Skip to main content
. 2020 Jun 3;12(2):197–201. doi: 10.4274/jcrpe.galenos.2019.2019.0108

Table 2. Correlation between soluble CD40 ligand and the other parameters in children with Graves’ disease.

graphic file with name JCRPE-12-197-g2.jpg